Pharma & Healthcare
Global Dog Vaccines Market Insights, Forecast to 2030
- Mar 07, 25
- ID: 271
- Pages: 109
- Figures: 132
- Views: 22
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.Cat Vaccines are kins of Vaccines for dogs
The global Dog Vaccines market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Dog Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Dog Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Dog Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Dog Vaccines include Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva, Eli Lilly, Heska Co., Merck Animal Health, Merial (Sanofi) and Virbac, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Dog Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Dog Vaccines, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Dog Vaccines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Dog Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Dog Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Dog Vaccines sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Boehringer Ingelheim
Ceva
Eli Lilly
Heska Co.
Merck Animal Health
Merial (Sanofi)
Virbac
Zoetis (Pfizer)
Segment by Type
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
Segment by Application
Below 6 Months
Above Months
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Dog Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Dog Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dog Vaccines sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
The global Dog Vaccines market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Dog Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Dog Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Dog Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Dog Vaccines include Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva, Eli Lilly, Heska Co., Merck Animal Health, Merial (Sanofi) and Virbac, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Dog Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Dog Vaccines, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Dog Vaccines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Dog Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Dog Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Dog Vaccines sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Boehringer Ingelheim
Ceva
Eli Lilly
Heska Co.
Merck Animal Health
Merial (Sanofi)
Virbac
Zoetis (Pfizer)
Segment by Type
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
Segment by Application
Below 6 Months
Above Months
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Dog Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Dog Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dog Vaccines sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Dog Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Dog Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Attenuated Live Vaccines
1.2.3 Conjugate Vaccines
1.2.4 Inactivated Vaccines
1.2.5 Subunit Vaccines
1.2.6 Toxoid Vaccines
1.2.7 DNA Vaccines
1.2.8 Recombinant Vaccines
1.3 Market by Application
1.3.1 Global Dog Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Below 6 Months
1.3.3 Above Months
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Dog Vaccines Sales Estimates and Forecasts 2019-2030
2.2 Global Dog Vaccines Revenue by Region
2.2.1 Global Dog Vaccines Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Dog Vaccines Revenue by Region (2019-2024)
2.2.3 Global Dog Vaccines Revenue by Region (2025-2030)
2.2.4 Global Dog Vaccines Revenue Market Share by Region (2019-2030)
2.3 Global Dog Vaccines Sales Estimates and Forecasts 2019-2030
2.4 Global Dog Vaccines Sales by Region
2.4.1 Global Dog Vaccines Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Dog Vaccines Sales by Region (2019-2024)
2.4.3 Global Dog Vaccines Sales by Region (2025-2030)
2.4.4 Global Dog Vaccines Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Dog Vaccines Sales by Manufacturers
3.1.1 Global Dog Vaccines Sales by Manufacturers (2019-2024)
3.1.2 Global Dog Vaccines Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dog Vaccines in 2023
3.2 Global Dog Vaccines Revenue by Manufacturers
3.2.1 Global Dog Vaccines Revenue by Manufacturers (2019-2024)
3.2.2 Global Dog Vaccines Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Dog Vaccines Revenue in 2023
3.3 Global Key Players of Dog Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Dog Vaccines Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Dog Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Dog Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Dog Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Dog Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Dog Vaccines Sales by Type
4.1.1 Global Dog Vaccines Historical Sales by Type (2019-2024)
4.1.2 Global Dog Vaccines Forecasted Sales by Type (2025-2030)
4.1.3 Global Dog Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Dog Vaccines Revenue by Type
4.2.1 Global Dog Vaccines Historical Revenue by Type (2019-2024)
4.2.2 Global Dog Vaccines Forecasted Revenue by Type (2025-2030)
4.2.3 Global Dog Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Dog Vaccines Price by Type
4.3.1 Global Dog Vaccines Price by Type (2019-2024)
4.3.2 Global Dog Vaccines Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Dog Vaccines Sales by Application
5.1.1 Global Dog Vaccines Historical Sales by Application (2019-2024)
5.1.2 Global Dog Vaccines Forecasted Sales by Application (2025-2030)
5.1.3 Global Dog Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Dog Vaccines Revenue by Application
5.2.1 Global Dog Vaccines Historical Revenue by Application (2019-2024)
5.2.2 Global Dog Vaccines Forecasted Revenue by Application (2025-2030)
5.2.3 Global Dog Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Dog Vaccines Price by Application
5.3.1 Global Dog Vaccines Price by Application (2019-2024)
5.3.2 Global Dog Vaccines Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Dog Vaccines Market Size by Type
6.1.1 US & Canada Dog Vaccines Sales by Type (2019-2030)
6.1.2 US & Canada Dog Vaccines Revenue by Type (2019-2030)
6.2 US & Canada Dog Vaccines Market Size by Application
6.2.1 US & Canada Dog Vaccines Sales by Application (2019-2030)
6.2.2 US & Canada Dog Vaccines Revenue by Application (2019-2030)
6.3 US & Canada Dog Vaccines Market Size by Country
6.3.1 US & Canada Dog Vaccines Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Dog Vaccines Sales by Country (2019-2030)
6.3.3 US & Canada Dog Vaccines Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Dog Vaccines Market Size by Type
7.1.1 Europe Dog Vaccines Sales by Type (2019-2030)
7.1.2 Europe Dog Vaccines Revenue by Type (2019-2030)
7.2 Europe Dog Vaccines Market Size by Application
7.2.1 Europe Dog Vaccines Sales by Application (2019-2030)
7.2.2 Europe Dog Vaccines Revenue by Application (2019-2030)
7.3 Europe Dog Vaccines Market Size by Country
7.3.1 Europe Dog Vaccines Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Dog Vaccines Sales by Country (2019-2030)
7.3.3 Europe Dog Vaccines Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Dog Vaccines Market Size
8.1.1 China Dog Vaccines Sales (2019-2030)
8.1.2 China Dog Vaccines Revenue (2019-2030)
8.2 China Dog Vaccines Market Size by Application
8.2.1 China Dog Vaccines Sales by Application (2019-2030)
8.2.2 China Dog Vaccines Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Dog Vaccines Market Size by Type
9.1.1 Asia Dog Vaccines Sales by Type (2019-2030)
9.1.2 Asia Dog Vaccines Revenue by Type (2019-2030)
9.2 Asia Dog Vaccines Market Size by Application
9.2.1 Asia Dog Vaccines Sales by Application (2019-2030)
9.2.2 Asia Dog Vaccines Revenue by Application (2019-2030)
9.3 Asia Dog Vaccines Sales by Region
9.3.1 Asia Dog Vaccines Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Dog Vaccines Revenue by Region (2019-2030)
9.3.3 Asia Dog Vaccines Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Dog Vaccines Market Size by Type
10.1.1 Middle East, Africa and Latin America Dog Vaccines Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Dog Vaccines Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Dog Vaccines Market Size by Application
10.2.1 Middle East, Africa and Latin America Dog Vaccines Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Dog Vaccines Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Dog Vaccines Sales by Country
10.3.1 Middle East, Africa and Latin America Dog Vaccines Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Dog Vaccines Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Dog Vaccines Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Bayer Healthcare
11.1.1 Bayer Healthcare Company Information
11.1.2 Bayer Healthcare Overview
11.1.3 Bayer Healthcare Dog Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Bayer Healthcare Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Healthcare Recent Developments
11.2 Vetoquinol S.A
11.2.1 Vetoquinol S.A Company Information
11.2.2 Vetoquinol S.A Overview
11.2.3 Vetoquinol S.A Dog Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Vetoquinol S.A Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Vetoquinol S.A Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Information
11.3.2 Boehringer Ingelheim Overview
11.3.3 Boehringer Ingelheim Dog Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Boehringer Ingelheim Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Boehringer Ingelheim Recent Developments
11.4 Ceva
11.4.1 Ceva Company Information
11.4.2 Ceva Overview
11.4.3 Ceva Dog Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Ceva Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ceva Recent Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Information
11.5.2 Eli Lilly Overview
11.5.3 Eli Lilly Dog Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Eli Lilly Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Eli Lilly Recent Developments
11.6 Heska Co.
11.6.1 Heska Co. Company Information
11.6.2 Heska Co. Overview
11.6.3 Heska Co. Dog Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Heska Co. Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Heska Co. Recent Developments
11.7 Merck Animal Health
11.7.1 Merck Animal Health Company Information
11.7.2 Merck Animal Health Overview
11.7.3 Merck Animal Health Dog Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Merck Animal Health Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Merck Animal Health Recent Developments
11.8 Merial (Sanofi)
11.8.1 Merial (Sanofi) Company Information
11.8.2 Merial (Sanofi) Overview
11.8.3 Merial (Sanofi) Dog Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Merial (Sanofi) Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Merial (Sanofi) Recent Developments
11.9 Virbac
11.9.1 Virbac Company Information
11.9.2 Virbac Overview
11.9.3 Virbac Dog Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Virbac Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Virbac Recent Developments
11.10 Zoetis (Pfizer)
11.10.1 Zoetis (Pfizer) Company Information
11.10.2 Zoetis (Pfizer) Overview
11.10.3 Zoetis (Pfizer) Dog Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Zoetis (Pfizer) Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Zoetis (Pfizer) Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Dog Vaccines Industry Chain Analysis
12.2 Dog Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Dog Vaccines Production Mode & Process
12.4 Dog Vaccines Sales and Marketing
12.4.1 Dog Vaccines Sales Channels
12.4.2 Dog Vaccines Distributors
12.5 Dog Vaccines Customers
13 Market Dynamics
13.1 Dog Vaccines Industry Trends
13.2 Dog Vaccines Market Drivers
13.3 Dog Vaccines Market Challenges
13.4 Dog Vaccines Market Restraints
14 Key Findings in The Global Dog Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
1.1 Dog Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Dog Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Attenuated Live Vaccines
1.2.3 Conjugate Vaccines
1.2.4 Inactivated Vaccines
1.2.5 Subunit Vaccines
1.2.6 Toxoid Vaccines
1.2.7 DNA Vaccines
1.2.8 Recombinant Vaccines
1.3 Market by Application
1.3.1 Global Dog Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Below 6 Months
1.3.3 Above Months
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Dog Vaccines Sales Estimates and Forecasts 2019-2030
2.2 Global Dog Vaccines Revenue by Region
2.2.1 Global Dog Vaccines Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Dog Vaccines Revenue by Region (2019-2024)
2.2.3 Global Dog Vaccines Revenue by Region (2025-2030)
2.2.4 Global Dog Vaccines Revenue Market Share by Region (2019-2030)
2.3 Global Dog Vaccines Sales Estimates and Forecasts 2019-2030
2.4 Global Dog Vaccines Sales by Region
2.4.1 Global Dog Vaccines Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Dog Vaccines Sales by Region (2019-2024)
2.4.3 Global Dog Vaccines Sales by Region (2025-2030)
2.4.4 Global Dog Vaccines Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Dog Vaccines Sales by Manufacturers
3.1.1 Global Dog Vaccines Sales by Manufacturers (2019-2024)
3.1.2 Global Dog Vaccines Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dog Vaccines in 2023
3.2 Global Dog Vaccines Revenue by Manufacturers
3.2.1 Global Dog Vaccines Revenue by Manufacturers (2019-2024)
3.2.2 Global Dog Vaccines Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Dog Vaccines Revenue in 2023
3.3 Global Key Players of Dog Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Dog Vaccines Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Dog Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Dog Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Dog Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Dog Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Dog Vaccines Sales by Type
4.1.1 Global Dog Vaccines Historical Sales by Type (2019-2024)
4.1.2 Global Dog Vaccines Forecasted Sales by Type (2025-2030)
4.1.3 Global Dog Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Dog Vaccines Revenue by Type
4.2.1 Global Dog Vaccines Historical Revenue by Type (2019-2024)
4.2.2 Global Dog Vaccines Forecasted Revenue by Type (2025-2030)
4.2.3 Global Dog Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Dog Vaccines Price by Type
4.3.1 Global Dog Vaccines Price by Type (2019-2024)
4.3.2 Global Dog Vaccines Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Dog Vaccines Sales by Application
5.1.1 Global Dog Vaccines Historical Sales by Application (2019-2024)
5.1.2 Global Dog Vaccines Forecasted Sales by Application (2025-2030)
5.1.3 Global Dog Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Dog Vaccines Revenue by Application
5.2.1 Global Dog Vaccines Historical Revenue by Application (2019-2024)
5.2.2 Global Dog Vaccines Forecasted Revenue by Application (2025-2030)
5.2.3 Global Dog Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Dog Vaccines Price by Application
5.3.1 Global Dog Vaccines Price by Application (2019-2024)
5.3.2 Global Dog Vaccines Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Dog Vaccines Market Size by Type
6.1.1 US & Canada Dog Vaccines Sales by Type (2019-2030)
6.1.2 US & Canada Dog Vaccines Revenue by Type (2019-2030)
6.2 US & Canada Dog Vaccines Market Size by Application
6.2.1 US & Canada Dog Vaccines Sales by Application (2019-2030)
6.2.2 US & Canada Dog Vaccines Revenue by Application (2019-2030)
6.3 US & Canada Dog Vaccines Market Size by Country
6.3.1 US & Canada Dog Vaccines Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Dog Vaccines Sales by Country (2019-2030)
6.3.3 US & Canada Dog Vaccines Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Dog Vaccines Market Size by Type
7.1.1 Europe Dog Vaccines Sales by Type (2019-2030)
7.1.2 Europe Dog Vaccines Revenue by Type (2019-2030)
7.2 Europe Dog Vaccines Market Size by Application
7.2.1 Europe Dog Vaccines Sales by Application (2019-2030)
7.2.2 Europe Dog Vaccines Revenue by Application (2019-2030)
7.3 Europe Dog Vaccines Market Size by Country
7.3.1 Europe Dog Vaccines Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Dog Vaccines Sales by Country (2019-2030)
7.3.3 Europe Dog Vaccines Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Dog Vaccines Market Size
8.1.1 China Dog Vaccines Sales (2019-2030)
8.1.2 China Dog Vaccines Revenue (2019-2030)
8.2 China Dog Vaccines Market Size by Application
8.2.1 China Dog Vaccines Sales by Application (2019-2030)
8.2.2 China Dog Vaccines Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Dog Vaccines Market Size by Type
9.1.1 Asia Dog Vaccines Sales by Type (2019-2030)
9.1.2 Asia Dog Vaccines Revenue by Type (2019-2030)
9.2 Asia Dog Vaccines Market Size by Application
9.2.1 Asia Dog Vaccines Sales by Application (2019-2030)
9.2.2 Asia Dog Vaccines Revenue by Application (2019-2030)
9.3 Asia Dog Vaccines Sales by Region
9.3.1 Asia Dog Vaccines Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Dog Vaccines Revenue by Region (2019-2030)
9.3.3 Asia Dog Vaccines Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Dog Vaccines Market Size by Type
10.1.1 Middle East, Africa and Latin America Dog Vaccines Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Dog Vaccines Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Dog Vaccines Market Size by Application
10.2.1 Middle East, Africa and Latin America Dog Vaccines Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Dog Vaccines Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Dog Vaccines Sales by Country
10.3.1 Middle East, Africa and Latin America Dog Vaccines Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Dog Vaccines Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Dog Vaccines Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Bayer Healthcare
11.1.1 Bayer Healthcare Company Information
11.1.2 Bayer Healthcare Overview
11.1.3 Bayer Healthcare Dog Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Bayer Healthcare Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Healthcare Recent Developments
11.2 Vetoquinol S.A
11.2.1 Vetoquinol S.A Company Information
11.2.2 Vetoquinol S.A Overview
11.2.3 Vetoquinol S.A Dog Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Vetoquinol S.A Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Vetoquinol S.A Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Information
11.3.2 Boehringer Ingelheim Overview
11.3.3 Boehringer Ingelheim Dog Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Boehringer Ingelheim Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Boehringer Ingelheim Recent Developments
11.4 Ceva
11.4.1 Ceva Company Information
11.4.2 Ceva Overview
11.4.3 Ceva Dog Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Ceva Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ceva Recent Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Information
11.5.2 Eli Lilly Overview
11.5.3 Eli Lilly Dog Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Eli Lilly Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Eli Lilly Recent Developments
11.6 Heska Co.
11.6.1 Heska Co. Company Information
11.6.2 Heska Co. Overview
11.6.3 Heska Co. Dog Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Heska Co. Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Heska Co. Recent Developments
11.7 Merck Animal Health
11.7.1 Merck Animal Health Company Information
11.7.2 Merck Animal Health Overview
11.7.3 Merck Animal Health Dog Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Merck Animal Health Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Merck Animal Health Recent Developments
11.8 Merial (Sanofi)
11.8.1 Merial (Sanofi) Company Information
11.8.2 Merial (Sanofi) Overview
11.8.3 Merial (Sanofi) Dog Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Merial (Sanofi) Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Merial (Sanofi) Recent Developments
11.9 Virbac
11.9.1 Virbac Company Information
11.9.2 Virbac Overview
11.9.3 Virbac Dog Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Virbac Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Virbac Recent Developments
11.10 Zoetis (Pfizer)
11.10.1 Zoetis (Pfizer) Company Information
11.10.2 Zoetis (Pfizer) Overview
11.10.3 Zoetis (Pfizer) Dog Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Zoetis (Pfizer) Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Zoetis (Pfizer) Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Dog Vaccines Industry Chain Analysis
12.2 Dog Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Dog Vaccines Production Mode & Process
12.4 Dog Vaccines Sales and Marketing
12.4.1 Dog Vaccines Sales Channels
12.4.2 Dog Vaccines Distributors
12.5 Dog Vaccines Customers
13 Market Dynamics
13.1 Dog Vaccines Industry Trends
13.2 Dog Vaccines Market Drivers
13.3 Dog Vaccines Market Challenges
13.4 Dog Vaccines Market Restraints
14 Key Findings in The Global Dog Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Dog Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Attenuated Live Vaccines
Table 3. Major Manufacturers of Conjugate Vaccines
Table 4. Major Manufacturers of Inactivated Vaccines
Table 5. Major Manufacturers of Subunit Vaccines
Table 6. Major Manufacturers of Toxoid Vaccines
Table 7. Major Manufacturers of DNA Vaccines
Table 8. Major Manufacturers of Recombinant Vaccines
Table 9. Global Dog Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 10. Global Dog Vaccines Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Dog Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 12. Global Dog Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 13. Global Dog Vaccines Revenue Market Share by Region (2019-2024)
Table 14. Global Dog Vaccines Revenue Market Share by Region (2025-2030)
Table 15. Global Dog Vaccines Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global Dog Vaccines Sales by Region (2019-2024) & (K Doses)
Table 17. Global Dog Vaccines Sales by Region (2025-2030) & (K Doses)
Table 18. Global Dog Vaccines Sales Market Share by Region (2019-2024)
Table 19. Global Dog Vaccines Sales Market Share by Region (2025-2030)
Table 20. Global Dog Vaccines Sales by Manufacturers (2019-2024) & (K Doses)
Table 21. Global Dog Vaccines Sales Share by Manufacturers (2019-2024)
Table 22. Global Dog Vaccines Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 23. Global Dog Vaccines Revenue Share by Manufacturers (2019-2024)
Table 24. Global Key Players of Dog Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 25. Dog Vaccines Price by Manufacturers 2019-2024 (USD/Dose)
Table 26. Global Dog Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Dog Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dog Vaccines as of 2023)
Table 28. Global Key Manufacturers of Dog Vaccines, Manufacturing Base Distribution and Headquarters
Table 29. Global Key Manufacturers of Dog Vaccines, Product Offered and Application
Table 30. Global Key Manufacturers of Dog Vaccines, Date of Enter into This Industry
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Dog Vaccines Sales by Type (2019-2024) & (K Doses)
Table 33. Global Dog Vaccines Sales by Type (2025-2030) & (K Doses)
Table 34. Global Dog Vaccines Sales Share by Type (2019-2024)
Table 35. Global Dog Vaccines Sales Share by Type (2025-2030)
Table 36. Global Dog Vaccines Revenue by Type (2019-2024) & (US$ Million)
Table 37. Global Dog Vaccines Revenue by Type (2025-2030) & (US$ Million)
Table 38. Global Dog Vaccines Revenue Share by Type (2019-2024)
Table 39. Global Dog Vaccines Revenue Share by Type (2025-2030)
Table 40. Dog Vaccines Price by Type (2019-2024) & (USD/Dose)
Table 41. Global Dog Vaccines Price Forecast by Type (2025-2030) & (USD/Dose)
Table 42. Global Dog Vaccines Sales by Application (2019-2024) & (K Doses)
Table 43. Global Dog Vaccines Sales by Application (2025-2030) & (K Doses)
Table 44. Global Dog Vaccines Sales Share by Application (2019-2024)
Table 45. Global Dog Vaccines Sales Share by Application (2025-2030)
Table 46. Global Dog Vaccines Revenue by Application (2019-2024) & (US$ Million)
Table 47. Global Dog Vaccines Revenue by Application (2025-2030) & (US$ Million)
Table 48. Global Dog Vaccines Revenue Share by Application (2019-2024)
Table 49. Global Dog Vaccines Revenue Share by Application (2025-2030)
Table 50. Dog Vaccines Price by Application (2019-2024) & (USD/Dose)
Table 51. Global Dog Vaccines Price Forecast by Application (2025-2030) & (USD/Dose)
Table 52. US & Canada Dog Vaccines Sales by Type (2019-2024) & (K Doses)
Table 53. US & Canada Dog Vaccines Sales by Type (2025-2030) & (K Doses)
Table 54. US & Canada Dog Vaccines Revenue by Type (2019-2024) & (US$ Million)
Table 55. US & Canada Dog Vaccines Revenue by Type (2025-2030) & (US$ Million)
Table 56. US & Canada Dog Vaccines Sales by Application (2019-2024) & (K Doses)
Table 57. US & Canada Dog Vaccines Sales by Application (2025-2030) & (K Doses)
Table 58. US & Canada Dog Vaccines Revenue by Application (2019-2024) & (US$ Million)
Table 59. US & Canada Dog Vaccines Revenue by Application (2025-2030) & (US$ Million)
Table 60. US & Canada Dog Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 61. US & Canada Dog Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 62. US & Canada Dog Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 63. US & Canada Dog Vaccines Sales by Country (2019-2024) & (K Doses)
Table 64. US & Canada Dog Vaccines Sales by Country (2025-2030) & (K Doses)
Table 65. Europe Dog Vaccines Sales by Type (2019-2024) & (K Doses)
Table 66. Europe Dog Vaccines Sales by Type (2025-2030) & (K Doses)
Table 67. Europe Dog Vaccines Revenue by Type (2019-2024) & (US$ Million)
Table 68. Europe Dog Vaccines Revenue by Type (2025-2030) & (US$ Million)
Table 69. Europe Dog Vaccines Sales by Application (2019-2024) & (K Doses)
Table 70. Europe Dog Vaccines Sales by Application (2025-2030) & (K Doses)
Table 71. Europe Dog Vaccines Revenue by Application (2019-2024) & (US$ Million)
Table 72. Europe Dog Vaccines Revenue by Application (2025-2030) & (US$ Million)
Table 73. Europe Dog Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 74. Europe Dog Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 75. Europe Dog Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 76. Europe Dog Vaccines Sales by Country (2019-2024) & (K Doses)
Table 77. Europe Dog Vaccines Sales by Country (2025-2030) & (K Doses)
Table 78. China Dog Vaccines Sales by Type (2019-2024) & (K Doses)
Table 79. China Dog Vaccines Sales by Type (2025-2030) & (K Doses)
Table 80. China Dog Vaccines Revenue by Type (2019-2024) & (US$ Million)
Table 81. China Dog Vaccines Revenue by Type (2025-2030) & (US$ Million)
Table 82. China Dog Vaccines Sales by Application (2019-2024) & (K Doses)
Table 83. China Dog Vaccines Sales by Application (2025-2030) & (K Doses)
Table 84. China Dog Vaccines Revenue by Application (2019-2024) & (US$ Million)
Table 85. China Dog Vaccines Revenue by Application (2025-2030) & (US$ Million)
Table 86. Asia Dog Vaccines Sales by Type (2019-2024) & (K Doses)
Table 87. Asia Dog Vaccines Sales by Type (2025-2030) & (K Doses)
Table 88. Asia Dog Vaccines Revenue by Type (2019-2024) & (US$ Million)
Table 89. Asia Dog Vaccines Revenue by Type (2025-2030) & (US$ Million)
Table 90. Asia Dog Vaccines Sales by Application (2019-2024) & (K Doses)
Table 91. Asia Dog Vaccines Sales by Application (2025-2030) & (K Doses)
Table 92. Asia Dog Vaccines Revenue by Application (2019-2024) & (US$ Million)
Table 93. Asia Dog Vaccines Revenue by Application (2025-2030) & (US$ Million)
Table 94. Asia Dog Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 95. Asia Dog Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 96. Asia Dog Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 97. Asia Dog Vaccines Sales by Region (2019-2024) & (K Doses)
Table 98. Asia Dog Vaccines Sales by Region (2025-2030) & (K Doses)
Table 99. Middle East, Africa and Latin America Dog Vaccines Sales by Type (2019-2024) & (K Doses)
Table 100. Middle East, Africa and Latin America Dog Vaccines Sales by Type (2025-2030) & (K Doses)
Table 101. Middle East, Africa and Latin America Dog Vaccines Revenue by Type (2019-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Dog Vaccines Revenue by Type (2025-2030) & (US$ Million)
Table 103. Middle East, Africa and Latin America Dog Vaccines Sales by Application (2019-2024) & (K Doses)
Table 104. Middle East, Africa and Latin America Dog Vaccines Sales by Application (2025-2030) & (K Doses)
Table 105. Middle East, Africa and Latin America Dog Vaccines Revenue by Application (2019-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Dog Vaccines Revenue by Application (2025-2030) & (US$ Million)
Table 107. Middle East, Africa and Latin America Dog Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 108. Middle East, Africa and Latin America Dog Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 109. Middle East, Africa and Latin America Dog Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 110. Middle East, Africa and Latin America Dog Vaccines Sales by Country (2019-2024) & (K Doses)
Table 111. Middle East, Africa and Latin America Dog Vaccines Sales by Country (2025-2030) & (K Doses)
Table 112. Bayer Healthcare Company Information
Table 113. Bayer Healthcare Description and Major Businesses
Table 114. Bayer Healthcare Dog Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 115. Bayer Healthcare Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Bayer Healthcare Recent Developments
Table 117. Vetoquinol S.A Company Information
Table 118. Vetoquinol S.A Description and Major Businesses
Table 119. Vetoquinol S.A Dog Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 120. Vetoquinol S.A Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Vetoquinol S.A Recent Developments
Table 122. Boehringer Ingelheim Company Information
Table 123. Boehringer Ingelheim Description and Major Businesses
Table 124. Boehringer Ingelheim Dog Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 125. Boehringer Ingelheim Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Boehringer Ingelheim Recent Developments
Table 127. Ceva Company Information
Table 128. Ceva Description and Major Businesses
Table 129. Ceva Dog Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 130. Ceva Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Ceva Recent Developments
Table 132. Eli Lilly Company Information
Table 133. Eli Lilly Description and Major Businesses
Table 134. Eli Lilly Dog Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 135. Eli Lilly Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Eli Lilly Recent Developments
Table 137. Heska Co. Company Information
Table 138. Heska Co. Description and Major Businesses
Table 139. Heska Co. Dog Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 140. Heska Co. Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Heska Co. Recent Developments
Table 142. Merck Animal Health Company Information
Table 143. Merck Animal Health Description and Major Businesses
Table 144. Merck Animal Health Dog Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 145. Merck Animal Health Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Merck Animal Health Recent Developments
Table 147. Merial (Sanofi) Company Information
Table 148. Merial (Sanofi) Description and Major Businesses
Table 149. Merial (Sanofi) Dog Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 150. Merial (Sanofi) Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Merial (Sanofi) Recent Developments
Table 152. Virbac Company Information
Table 153. Virbac Description and Major Businesses
Table 154. Virbac Dog Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 155. Virbac Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Virbac Recent Developments
Table 157. Zoetis (Pfizer) Company Information
Table 158. Zoetis (Pfizer) Description and Major Businesses
Table 159. Zoetis (Pfizer) Dog Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 160. Zoetis (Pfizer) Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Zoetis (Pfizer) Recent Developments
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Dog Vaccines Distributors List
Table 165. Dog Vaccines Customers List
Table 166. Dog Vaccines Market Trends
Table 167. Dog Vaccines Market Drivers
Table 168. Dog Vaccines Market Challenges
Table 169. Dog Vaccines Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Dog Vaccines Product Picture
Figure 2. Global Dog Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Dog Vaccines Market Share by Type in 2023 & 2030
Figure 4. Attenuated Live Vaccines Product Picture
Figure 5. Conjugate Vaccines Product Picture
Figure 6. Inactivated Vaccines Product Picture
Figure 7. Subunit Vaccines Product Picture
Figure 8. Toxoid Vaccines Product Picture
Figure 9. DNA Vaccines Product Picture
Figure 10. Recombinant Vaccines Product Picture
Figure 11. Global Dog Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 12. Global Dog Vaccines Market Share by Application in 2023 & 2030
Figure 13. Below 6 Months
Figure 14. Above Months
Figure 15. Dog Vaccines Report Years Considered
Figure 16. Global Dog Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Dog Vaccines Revenue 2019-2030 (US$ Million)
Figure 18. Global Dog Vaccines Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 19. Global Dog Vaccines Revenue Market Share by Region (2019-2030)
Figure 20. Global Dog Vaccines Sales 2019-2030 ((K Doses)
Figure 21. Global Dog Vaccines Sales Market Share by Region (2019-2030)
Figure 22. US & Canada Dog Vaccines Sales YoY (2019-2030) & (K Doses)
Figure 23. US & Canada Dog Vaccines Revenue YoY (2019-2030) & (US$ Million)
Figure 24. Europe Dog Vaccines Sales YoY (2019-2030) & (K Doses)
Figure 25. Europe Dog Vaccines Revenue YoY (2019-2030) & (US$ Million)
Figure 26. China Dog Vaccines Sales YoY (2019-2030) & (K Doses)
Figure 27. China Dog Vaccines Revenue YoY (2019-2030) & (US$ Million)
Figure 28. Asia (excluding China) Dog Vaccines Sales YoY (2019-2030) & (K Doses)
Figure 29. Asia (excluding China) Dog Vaccines Revenue YoY (2019-2030) & (US$ Million)
Figure 30. Middle East, Africa and Latin America Dog Vaccines Sales YoY (2019-2030) & (K Doses)
Figure 31. Middle East, Africa and Latin America Dog Vaccines Revenue YoY (2019-2030) & (US$ Million)
Figure 32. The Dog Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 33. The Top 5 and 10 Largest Manufacturers of Dog Vaccines in the World: Market Share by Dog Vaccines Revenue in 2023
Figure 34. Global Dog Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 35. Global Dog Vaccines Sales Market Share by Type (2019-2030)
Figure 36. Global Dog Vaccines Revenue Market Share by Type (2019-2030)
Figure 37. Global Dog Vaccines Sales Market Share by Application (2019-2030)
Figure 38. Global Dog Vaccines Revenue Market Share by Application (2019-2030)
Figure 39. US & Canada Dog Vaccines Sales Market Share by Type (2019-2030)
Figure 40. US & Canada Dog Vaccines Revenue Market Share by Type (2019-2030)
Figure 41. US & Canada Dog Vaccines Sales Market Share by Application (2019-2030)
Figure 42. US & Canada Dog Vaccines Revenue Market Share by Application (2019-2030)
Figure 43. US & Canada Dog Vaccines Revenue Share by Country (2019-2030)
Figure 44. US & Canada Dog Vaccines Sales Share by Country (2019-2030)
Figure 45. U.S. Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 46. Canada Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 47. Europe Dog Vaccines Sales Market Share by Type (2019-2030)
Figure 48. Europe Dog Vaccines Revenue Market Share by Type (2019-2030)
Figure 49. Europe Dog Vaccines Sales Market Share by Application (2019-2030)
Figure 50. Europe Dog Vaccines Revenue Market Share by Application (2019-2030)
Figure 51. Europe Dog Vaccines Revenue Share by Country (2019-2030)
Figure 52. Europe Dog Vaccines Sales Share by Country (2019-2030)
Figure 53. Germany Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 54. France Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 55. U.K. Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 56. Italy Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 57. Russia Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 58. China Dog Vaccines Sales Market Share by Type (2019-2030)
Figure 59. China Dog Vaccines Revenue Market Share by Type (2019-2030)
Figure 60. China Dog Vaccines Sales Market Share by Application (2019-2030)
Figure 61. China Dog Vaccines Revenue Market Share by Application (2019-2030)
Figure 62. Asia Dog Vaccines Sales Market Share by Type (2019-2030)
Figure 63. Asia Dog Vaccines Revenue Market Share by Type (2019-2030)
Figure 64. Asia Dog Vaccines Sales Market Share by Application (2019-2030)
Figure 65. Asia Dog Vaccines Revenue Market Share by Application (2019-2030)
Figure 66. Asia Dog Vaccines Revenue Share by Region (2019-2030)
Figure 67. Asia Dog Vaccines Sales Share by Region (2019-2030)
Figure 68. Japan Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 69. South Korea Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 70. China Taiwan Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 71. Southeast Asia Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 72. India Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 73. Middle East, Africa and Latin America Dog Vaccines Sales Market Share by Type (2019-2030)
Figure 74. Middle East, Africa and Latin America Dog Vaccines Revenue Market Share by Type (2019-2030)
Figure 75. Middle East, Africa and Latin America Dog Vaccines Sales Market Share by Application (2019-2030)
Figure 76. Middle East, Africa and Latin America Dog Vaccines Revenue Market Share by Application (2019-2030)
Figure 77. Middle East, Africa and Latin America Dog Vaccines Revenue Share by Country (2019-2030)
Figure 78. Middle East, Africa and Latin America Dog Vaccines Sales Share by Country (2019-2030)
Figure 79. Brazil Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 80. Mexico Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 81. Turkey Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 82. Israel Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 83. GCC Countries Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 84. Dog Vaccines Value Chain
Figure 85. Dog Vaccines Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
Table 1. Global Dog Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Attenuated Live Vaccines
Table 3. Major Manufacturers of Conjugate Vaccines
Table 4. Major Manufacturers of Inactivated Vaccines
Table 5. Major Manufacturers of Subunit Vaccines
Table 6. Major Manufacturers of Toxoid Vaccines
Table 7. Major Manufacturers of DNA Vaccines
Table 8. Major Manufacturers of Recombinant Vaccines
Table 9. Global Dog Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 10. Global Dog Vaccines Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Dog Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 12. Global Dog Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 13. Global Dog Vaccines Revenue Market Share by Region (2019-2024)
Table 14. Global Dog Vaccines Revenue Market Share by Region (2025-2030)
Table 15. Global Dog Vaccines Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global Dog Vaccines Sales by Region (2019-2024) & (K Doses)
Table 17. Global Dog Vaccines Sales by Region (2025-2030) & (K Doses)
Table 18. Global Dog Vaccines Sales Market Share by Region (2019-2024)
Table 19. Global Dog Vaccines Sales Market Share by Region (2025-2030)
Table 20. Global Dog Vaccines Sales by Manufacturers (2019-2024) & (K Doses)
Table 21. Global Dog Vaccines Sales Share by Manufacturers (2019-2024)
Table 22. Global Dog Vaccines Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 23. Global Dog Vaccines Revenue Share by Manufacturers (2019-2024)
Table 24. Global Key Players of Dog Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 25. Dog Vaccines Price by Manufacturers 2019-2024 (USD/Dose)
Table 26. Global Dog Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Dog Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dog Vaccines as of 2023)
Table 28. Global Key Manufacturers of Dog Vaccines, Manufacturing Base Distribution and Headquarters
Table 29. Global Key Manufacturers of Dog Vaccines, Product Offered and Application
Table 30. Global Key Manufacturers of Dog Vaccines, Date of Enter into This Industry
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Dog Vaccines Sales by Type (2019-2024) & (K Doses)
Table 33. Global Dog Vaccines Sales by Type (2025-2030) & (K Doses)
Table 34. Global Dog Vaccines Sales Share by Type (2019-2024)
Table 35. Global Dog Vaccines Sales Share by Type (2025-2030)
Table 36. Global Dog Vaccines Revenue by Type (2019-2024) & (US$ Million)
Table 37. Global Dog Vaccines Revenue by Type (2025-2030) & (US$ Million)
Table 38. Global Dog Vaccines Revenue Share by Type (2019-2024)
Table 39. Global Dog Vaccines Revenue Share by Type (2025-2030)
Table 40. Dog Vaccines Price by Type (2019-2024) & (USD/Dose)
Table 41. Global Dog Vaccines Price Forecast by Type (2025-2030) & (USD/Dose)
Table 42. Global Dog Vaccines Sales by Application (2019-2024) & (K Doses)
Table 43. Global Dog Vaccines Sales by Application (2025-2030) & (K Doses)
Table 44. Global Dog Vaccines Sales Share by Application (2019-2024)
Table 45. Global Dog Vaccines Sales Share by Application (2025-2030)
Table 46. Global Dog Vaccines Revenue by Application (2019-2024) & (US$ Million)
Table 47. Global Dog Vaccines Revenue by Application (2025-2030) & (US$ Million)
Table 48. Global Dog Vaccines Revenue Share by Application (2019-2024)
Table 49. Global Dog Vaccines Revenue Share by Application (2025-2030)
Table 50. Dog Vaccines Price by Application (2019-2024) & (USD/Dose)
Table 51. Global Dog Vaccines Price Forecast by Application (2025-2030) & (USD/Dose)
Table 52. US & Canada Dog Vaccines Sales by Type (2019-2024) & (K Doses)
Table 53. US & Canada Dog Vaccines Sales by Type (2025-2030) & (K Doses)
Table 54. US & Canada Dog Vaccines Revenue by Type (2019-2024) & (US$ Million)
Table 55. US & Canada Dog Vaccines Revenue by Type (2025-2030) & (US$ Million)
Table 56. US & Canada Dog Vaccines Sales by Application (2019-2024) & (K Doses)
Table 57. US & Canada Dog Vaccines Sales by Application (2025-2030) & (K Doses)
Table 58. US & Canada Dog Vaccines Revenue by Application (2019-2024) & (US$ Million)
Table 59. US & Canada Dog Vaccines Revenue by Application (2025-2030) & (US$ Million)
Table 60. US & Canada Dog Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 61. US & Canada Dog Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 62. US & Canada Dog Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 63. US & Canada Dog Vaccines Sales by Country (2019-2024) & (K Doses)
Table 64. US & Canada Dog Vaccines Sales by Country (2025-2030) & (K Doses)
Table 65. Europe Dog Vaccines Sales by Type (2019-2024) & (K Doses)
Table 66. Europe Dog Vaccines Sales by Type (2025-2030) & (K Doses)
Table 67. Europe Dog Vaccines Revenue by Type (2019-2024) & (US$ Million)
Table 68. Europe Dog Vaccines Revenue by Type (2025-2030) & (US$ Million)
Table 69. Europe Dog Vaccines Sales by Application (2019-2024) & (K Doses)
Table 70. Europe Dog Vaccines Sales by Application (2025-2030) & (K Doses)
Table 71. Europe Dog Vaccines Revenue by Application (2019-2024) & (US$ Million)
Table 72. Europe Dog Vaccines Revenue by Application (2025-2030) & (US$ Million)
Table 73. Europe Dog Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 74. Europe Dog Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 75. Europe Dog Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 76. Europe Dog Vaccines Sales by Country (2019-2024) & (K Doses)
Table 77. Europe Dog Vaccines Sales by Country (2025-2030) & (K Doses)
Table 78. China Dog Vaccines Sales by Type (2019-2024) & (K Doses)
Table 79. China Dog Vaccines Sales by Type (2025-2030) & (K Doses)
Table 80. China Dog Vaccines Revenue by Type (2019-2024) & (US$ Million)
Table 81. China Dog Vaccines Revenue by Type (2025-2030) & (US$ Million)
Table 82. China Dog Vaccines Sales by Application (2019-2024) & (K Doses)
Table 83. China Dog Vaccines Sales by Application (2025-2030) & (K Doses)
Table 84. China Dog Vaccines Revenue by Application (2019-2024) & (US$ Million)
Table 85. China Dog Vaccines Revenue by Application (2025-2030) & (US$ Million)
Table 86. Asia Dog Vaccines Sales by Type (2019-2024) & (K Doses)
Table 87. Asia Dog Vaccines Sales by Type (2025-2030) & (K Doses)
Table 88. Asia Dog Vaccines Revenue by Type (2019-2024) & (US$ Million)
Table 89. Asia Dog Vaccines Revenue by Type (2025-2030) & (US$ Million)
Table 90. Asia Dog Vaccines Sales by Application (2019-2024) & (K Doses)
Table 91. Asia Dog Vaccines Sales by Application (2025-2030) & (K Doses)
Table 92. Asia Dog Vaccines Revenue by Application (2019-2024) & (US$ Million)
Table 93. Asia Dog Vaccines Revenue by Application (2025-2030) & (US$ Million)
Table 94. Asia Dog Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 95. Asia Dog Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 96. Asia Dog Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 97. Asia Dog Vaccines Sales by Region (2019-2024) & (K Doses)
Table 98. Asia Dog Vaccines Sales by Region (2025-2030) & (K Doses)
Table 99. Middle East, Africa and Latin America Dog Vaccines Sales by Type (2019-2024) & (K Doses)
Table 100. Middle East, Africa and Latin America Dog Vaccines Sales by Type (2025-2030) & (K Doses)
Table 101. Middle East, Africa and Latin America Dog Vaccines Revenue by Type (2019-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Dog Vaccines Revenue by Type (2025-2030) & (US$ Million)
Table 103. Middle East, Africa and Latin America Dog Vaccines Sales by Application (2019-2024) & (K Doses)
Table 104. Middle East, Africa and Latin America Dog Vaccines Sales by Application (2025-2030) & (K Doses)
Table 105. Middle East, Africa and Latin America Dog Vaccines Revenue by Application (2019-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Dog Vaccines Revenue by Application (2025-2030) & (US$ Million)
Table 107. Middle East, Africa and Latin America Dog Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 108. Middle East, Africa and Latin America Dog Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 109. Middle East, Africa and Latin America Dog Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 110. Middle East, Africa and Latin America Dog Vaccines Sales by Country (2019-2024) & (K Doses)
Table 111. Middle East, Africa and Latin America Dog Vaccines Sales by Country (2025-2030) & (K Doses)
Table 112. Bayer Healthcare Company Information
Table 113. Bayer Healthcare Description and Major Businesses
Table 114. Bayer Healthcare Dog Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 115. Bayer Healthcare Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Bayer Healthcare Recent Developments
Table 117. Vetoquinol S.A Company Information
Table 118. Vetoquinol S.A Description and Major Businesses
Table 119. Vetoquinol S.A Dog Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 120. Vetoquinol S.A Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Vetoquinol S.A Recent Developments
Table 122. Boehringer Ingelheim Company Information
Table 123. Boehringer Ingelheim Description and Major Businesses
Table 124. Boehringer Ingelheim Dog Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 125. Boehringer Ingelheim Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Boehringer Ingelheim Recent Developments
Table 127. Ceva Company Information
Table 128. Ceva Description and Major Businesses
Table 129. Ceva Dog Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 130. Ceva Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Ceva Recent Developments
Table 132. Eli Lilly Company Information
Table 133. Eli Lilly Description and Major Businesses
Table 134. Eli Lilly Dog Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 135. Eli Lilly Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Eli Lilly Recent Developments
Table 137. Heska Co. Company Information
Table 138. Heska Co. Description and Major Businesses
Table 139. Heska Co. Dog Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 140. Heska Co. Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Heska Co. Recent Developments
Table 142. Merck Animal Health Company Information
Table 143. Merck Animal Health Description and Major Businesses
Table 144. Merck Animal Health Dog Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 145. Merck Animal Health Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Merck Animal Health Recent Developments
Table 147. Merial (Sanofi) Company Information
Table 148. Merial (Sanofi) Description and Major Businesses
Table 149. Merial (Sanofi) Dog Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 150. Merial (Sanofi) Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Merial (Sanofi) Recent Developments
Table 152. Virbac Company Information
Table 153. Virbac Description and Major Businesses
Table 154. Virbac Dog Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 155. Virbac Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Virbac Recent Developments
Table 157. Zoetis (Pfizer) Company Information
Table 158. Zoetis (Pfizer) Description and Major Businesses
Table 159. Zoetis (Pfizer) Dog Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 160. Zoetis (Pfizer) Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Zoetis (Pfizer) Recent Developments
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Dog Vaccines Distributors List
Table 165. Dog Vaccines Customers List
Table 166. Dog Vaccines Market Trends
Table 167. Dog Vaccines Market Drivers
Table 168. Dog Vaccines Market Challenges
Table 169. Dog Vaccines Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Dog Vaccines Product Picture
Figure 2. Global Dog Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Dog Vaccines Market Share by Type in 2023 & 2030
Figure 4. Attenuated Live Vaccines Product Picture
Figure 5. Conjugate Vaccines Product Picture
Figure 6. Inactivated Vaccines Product Picture
Figure 7. Subunit Vaccines Product Picture
Figure 8. Toxoid Vaccines Product Picture
Figure 9. DNA Vaccines Product Picture
Figure 10. Recombinant Vaccines Product Picture
Figure 11. Global Dog Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 12. Global Dog Vaccines Market Share by Application in 2023 & 2030
Figure 13. Below 6 Months
Figure 14. Above Months
Figure 15. Dog Vaccines Report Years Considered
Figure 16. Global Dog Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Dog Vaccines Revenue 2019-2030 (US$ Million)
Figure 18. Global Dog Vaccines Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 19. Global Dog Vaccines Revenue Market Share by Region (2019-2030)
Figure 20. Global Dog Vaccines Sales 2019-2030 ((K Doses)
Figure 21. Global Dog Vaccines Sales Market Share by Region (2019-2030)
Figure 22. US & Canada Dog Vaccines Sales YoY (2019-2030) & (K Doses)
Figure 23. US & Canada Dog Vaccines Revenue YoY (2019-2030) & (US$ Million)
Figure 24. Europe Dog Vaccines Sales YoY (2019-2030) & (K Doses)
Figure 25. Europe Dog Vaccines Revenue YoY (2019-2030) & (US$ Million)
Figure 26. China Dog Vaccines Sales YoY (2019-2030) & (K Doses)
Figure 27. China Dog Vaccines Revenue YoY (2019-2030) & (US$ Million)
Figure 28. Asia (excluding China) Dog Vaccines Sales YoY (2019-2030) & (K Doses)
Figure 29. Asia (excluding China) Dog Vaccines Revenue YoY (2019-2030) & (US$ Million)
Figure 30. Middle East, Africa and Latin America Dog Vaccines Sales YoY (2019-2030) & (K Doses)
Figure 31. Middle East, Africa and Latin America Dog Vaccines Revenue YoY (2019-2030) & (US$ Million)
Figure 32. The Dog Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 33. The Top 5 and 10 Largest Manufacturers of Dog Vaccines in the World: Market Share by Dog Vaccines Revenue in 2023
Figure 34. Global Dog Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 35. Global Dog Vaccines Sales Market Share by Type (2019-2030)
Figure 36. Global Dog Vaccines Revenue Market Share by Type (2019-2030)
Figure 37. Global Dog Vaccines Sales Market Share by Application (2019-2030)
Figure 38. Global Dog Vaccines Revenue Market Share by Application (2019-2030)
Figure 39. US & Canada Dog Vaccines Sales Market Share by Type (2019-2030)
Figure 40. US & Canada Dog Vaccines Revenue Market Share by Type (2019-2030)
Figure 41. US & Canada Dog Vaccines Sales Market Share by Application (2019-2030)
Figure 42. US & Canada Dog Vaccines Revenue Market Share by Application (2019-2030)
Figure 43. US & Canada Dog Vaccines Revenue Share by Country (2019-2030)
Figure 44. US & Canada Dog Vaccines Sales Share by Country (2019-2030)
Figure 45. U.S. Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 46. Canada Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 47. Europe Dog Vaccines Sales Market Share by Type (2019-2030)
Figure 48. Europe Dog Vaccines Revenue Market Share by Type (2019-2030)
Figure 49. Europe Dog Vaccines Sales Market Share by Application (2019-2030)
Figure 50. Europe Dog Vaccines Revenue Market Share by Application (2019-2030)
Figure 51. Europe Dog Vaccines Revenue Share by Country (2019-2030)
Figure 52. Europe Dog Vaccines Sales Share by Country (2019-2030)
Figure 53. Germany Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 54. France Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 55. U.K. Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 56. Italy Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 57. Russia Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 58. China Dog Vaccines Sales Market Share by Type (2019-2030)
Figure 59. China Dog Vaccines Revenue Market Share by Type (2019-2030)
Figure 60. China Dog Vaccines Sales Market Share by Application (2019-2030)
Figure 61. China Dog Vaccines Revenue Market Share by Application (2019-2030)
Figure 62. Asia Dog Vaccines Sales Market Share by Type (2019-2030)
Figure 63. Asia Dog Vaccines Revenue Market Share by Type (2019-2030)
Figure 64. Asia Dog Vaccines Sales Market Share by Application (2019-2030)
Figure 65. Asia Dog Vaccines Revenue Market Share by Application (2019-2030)
Figure 66. Asia Dog Vaccines Revenue Share by Region (2019-2030)
Figure 67. Asia Dog Vaccines Sales Share by Region (2019-2030)
Figure 68. Japan Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 69. South Korea Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 70. China Taiwan Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 71. Southeast Asia Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 72. India Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 73. Middle East, Africa and Latin America Dog Vaccines Sales Market Share by Type (2019-2030)
Figure 74. Middle East, Africa and Latin America Dog Vaccines Revenue Market Share by Type (2019-2030)
Figure 75. Middle East, Africa and Latin America Dog Vaccines Sales Market Share by Application (2019-2030)
Figure 76. Middle East, Africa and Latin America Dog Vaccines Revenue Market Share by Application (2019-2030)
Figure 77. Middle East, Africa and Latin America Dog Vaccines Revenue Share by Country (2019-2030)
Figure 78. Middle East, Africa and Latin America Dog Vaccines Sales Share by Country (2019-2030)
Figure 79. Brazil Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 80. Mexico Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 81. Turkey Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 82. Israel Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 83. GCC Countries Dog Vaccines Revenue (2019-2030) & (US$ Million)
Figure 84. Dog Vaccines Value Chain
Figure 85. Dog Vaccines Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Coke Oven Inspection Intelligent Robot Market Research Report 2025
Apr 16, 25
Global Explosion-Proof Fire Extinguishing Reconnaissance Robot Market Research Report 2025
Apr 16, 25
Global Electric Wheeled Inspection Robot Market Research Report 2025
Apr 16, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232